TrialDiabetes, obesity & metabolism2026

Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis.

João Sérgio Neves et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.